Liberty Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Liberty Wealth Management's BMY Position: Q1 2026 in Review
Liberty Wealth Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 4,286 shares worth $260K. The stake represents 0.03% of the portfolio and ranks #225 among its holdings. This is a return to the name: Liberty Wealth Management previously reported a position in BMY as recently as Q4 2024.
Liberty Wealth Management first reported a position in BMY in Q4 2018 and has held it in 22 quarters since. The position peaked at $427K in Q1 2021. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Liberty Wealth Management held 4,286 shares of Bristol-Myers Squibb worth $260K as of Q1 2026.
- Bristol-Myers Squibb was a new Liberty Wealth Management position in Q1 2026.
- Bristol-Myers Squibb made up 0.03% of Liberty Wealth Management's portfolio in Q1 2026, its #225 holding.
- Liberty Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 22 quarters since.
- Liberty Wealth Management's Bristol-Myers Squibb position peaked at $427K in Q1 2021.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Liberty Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.